Alvotech is trading 6.03% down at ISK 592 after a strong recent rally, with no fresh company-specific negative announcement identified for the August 26 decline.
- Alvotech closed at ISK 628 on August 24.
- Recent gains followed the Lotus Pharmaceutical licensing agreement, FDA inspection progress and first-half results.